Immuno-cell therapy of cancer in Japan

Anticancer Res. Sep-Oct 2004;24(5C):3321-6.

Abstract

The immuno-cell therapy of cancer in Japan is in the phase of transition from therapeutic research to a more generalized option for all patients. A short history of cancer immunotherapy in Japan and its present status are summarized. In 1999, the first private clinic with a cell processing facility and specializing in immuno-cell therapy was established. Since then, the number of such clinics has increased. As a result, the number of patients who undergone the therapy has markedly increased. A summary of the clinical results of the therapy in 1401 patients treated in two leading clinics is also presented.

Publication types

  • Review

MeSH terms

  • Combined Modality Therapy
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Immunotherapy, Adoptive / trends
  • Japan
  • Killer Cells, Lymphokine-Activated / immunology
  • Neoplasms / immunology*
  • Neoplasms / therapy*